Literature DB >> 2257853

Measurement of drug use in a defined population. Evaluation of the defined daily dose (DDD) methodology.

A Wessling1, G Boëthius.   

Abstract

To evaluate the accuracy of the DDD per 1000 inhabitants per unit time as an estimate of the fraction of drug users within a population, DDD figures have been compared with the proportion of apparent drug users, i.e. individuals in the population for who a prescriptions had been dispensed. An individual-based prescription monitoring project provided the necessary data for eight drugs representing continuous long-term medication, short-term medication and medication falling in between those two categories. For digoxin, the long-term drug, the number of DDD/1000 inhabitants/day was about 40% below the proportion of apparent drug users. The DDD figure for antibiotics ranged from 4% below to 28% above the apparent users, and for the remaining drugs it ranged from 17% below (bendroflumethiazide, 1982) to 80% below (naproxen, 1985). The DDD methodology is a valuable first step in overall drug use measurement, but for more precise estimates of drug use it must be supplemented by other techniques.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2257853     DOI: 10.1007/bf00315097

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  Recording of drug prescriptions in the county of Jämtland, Sweden. I. Methodological aspects.

Authors:  G Boethius; F Wiman
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

2.  [The Gotland's study: high prescription rate of diabetic agents but also high morbidity].

Authors:  L Idman; U Bergman; M Dahlén; L Martinsson; A Wessling
Journal:  Lakartidningen       Date:  1985-03-20

3.  Drug utilization and morbidity statistics for the evaluation of drug safety in Sweden.

Authors:  B E Wiholm; B Westerholm
Journal:  Acta Med Scand Suppl       Date:  1984

4.  Utilization of antidiabetic drugs in the Island of Gotland, Sweden: agreement between wholesale figures and prescription data.

Authors:  U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

5.  The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden.

Authors:  U Bergman; P Elmes; M Halse; T Halvorsen; H Hood; P K Lunde; F Sjöqvist; O L Wade; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

6.  Patterns in drug utilization--national and international aspects: antidiabetic drugs.

Authors:  L Stika
Journal:  Acta Med Scand Suppl       Date:  1984
  6 in total
  13 in total

1.  Drug utilization in general practice: prescribing habits of National Formulary drugs by GPs of Emilia Romagna (Italy) in 1988 and 1989.

Authors:  N Montanaro; N Magrini; A Vaccheri; M Battilana
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Consumption of antibiotics in Sweden, 1975 to 1992: pharmacoeconomic and clinical aspects.

Authors:  S R Norrby
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

Review 3.  Drug utilisation studies as tools in health economics.

Authors:  J A Sacristán; J Soto
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

4.  Quality assessment of drug sales data: the case of antibacterials in Iceland.

Authors:  I Björnsdóttir; E H Hansen; A Grímsson
Journal:  Pharm World Sci       Date:  1999-10

5.  Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults.

Authors:  Mary E Tinetti; Ling Han; David S H Lee; Gail J McAvay; Peter Peduzzi; Cary P Gross; Bingqing Zhou; Haiqun Lin
Journal:  JAMA Intern Med       Date:  2014-04       Impact factor: 21.873

6.  Antidepressants in suicide: differences in fatality and drug utilisation.

Authors:  J Malmvik; C G Löwenhielm; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

7.  Application of the ATC/DDD methodology to monitor antibiotic drug use.

Authors:  S Natsch; Y A Hekster; R de Jong; E R Heerdink; R M Herings; J W van der Meer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

8.  Cisapride and ventricular arrhythmia.

Authors:  Sean Hennessy; Charles E Leonard; Craig Newcomb; Stephen E Kimmel; Warren B Bilker
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

9.  Large intercommunity difference in cardiovascular drug consumption: relation to mortality, risk factors and socioeconomic differences.

Authors:  M Oreberg; G G Jonsson; K West; M Eberhard-Grahn; L Råstam; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 10.  Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective.

Authors:  Stephan Harbarth; Werner Albrich; Christian Brun-Buisson
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.